Australia markets closed

Xenon Pharmaceuticals Inc. (XENE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
38.47-1.38 (-3.46%)
At close: 04:00PM EDT
37.50 -0.97 (-2.52%)
After hours: 07:10PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-199,060
-182,393
-125,373
-78,882
-28,837
-
Depreciation & amortisation
3,843
3,541
1,624
906
644
-
Deferred income taxes
-286
-292
-44
58
-285
-
Stock-based compensation
42,041
32,372
20,376
10,017
5,677
-
Change in working capital
616
5,635
-676
-2,647
-26,089
-
Accounts receivable
-123
130
1,757
-459
-1,032
-
Other working capital
-156,532
-150,944
-101,324
-71,552
-50,761
-
Other non-cash items
-
-
-
-
216
525
Net cash provided by operating activities
-153,552
-145,327
-98,430
-69,502
-48,124
-
Cash flows from investing activities
Investments in property, plant and equipment
-2,980
-5,617
-2,894
-2,050
-2,637
-
Purchases of investments
-825,179
-793,907
-551,137
-389,474
-228,897
-
Sales/maturities of investments
700,982
682,354
258,028
144,754
214,710
-
Net cash used for investing activities
-127,177
-117,170
-296,003
-246,770
-16,824
-
Cash flows from financing activities
Debt repayment
-
-
0
0
-16,743
0
Common stock issued
-
353,487
277,766
447,283
102,456
-
Net cash used provided by (used for) financing activities
-
353,522
278,471
447,543
85,795
-
Net change in cash
72,182
91,401
-118,446
130,679
20,254
-
Cash at beginning of period
64,552
57,242
175,688
45,009
24,755
-
Cash at end of period
137,345
148,643
57,242
175,688
45,009
-
Free cash flow
Operating cash flow
-153,552
-145,327
-98,430
-69,502
-48,124
-
Capital expenditure
-2,980
-5,617
-2,894
-2,050
-2,637
-
Free cash flow
-156,532
-150,944
-101,324
-71,552
-50,761
-